New Zealand markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
581.21+1.84 (+0.32%)
At close: 04:00PM EDT
579.13 -2.08 (-0.36%)
After hours: 07:30PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
5,995,000
5,995,000
6,950,000
7,725,000
6,375,000
Depreciation & amortisation
3,406,000
3,406,000
3,381,000
2,592,000
2,325,000
Deferred income taxes
-1,300,000
-1,300,000
-995,000
-647,000
-552,000
Stock-based compensation
278,000
278,000
307,000
230,000
196,000
Change in working capital
-495,000
-495,000
-1,008,000
-1,514,000
-299,000
Accounts receivable
-43,000
-43,000
-430,000
-204,000
-1,302,000
Inventory
598,000
598,000
-825,000
-1,065,000
-508,000
Accounts payable
-500,000
-500,000
648,000
479,000
59,000
Other working capital
6,927,000
6,927,000
6,911,000
6,789,000
6,815,000
Other non-cash items
562,000
562,000
483,000
156,000
242,000
Net cash provided by operating activities
8,406,000
8,406,000
9,154,000
9,312,000
8,289,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,479,000
-1,479,000
-2,243,000
-2,523,000
-1,474,000
Acquisitions, net
-3,660,000
-3,660,000
-39,000
-19,395,000
-38,000
Sales/maturities of investments
70,000
70,000
15,000
8,000
-
Other investing activities
-160,000
-160,000
84,000
-42,000
-6,000
Net cash used for investing activities
-5,142,000
-5,142,000
-2,159,000
-21,932,000
-1,510,000
Cash flows from financing activities
Debt repayment
-7,717,000
-7,717,000
-4,065,000
-11,738,000
-1,097,000
Common stock repurchased
-3,000,000
-3,000,000
-3,000,000
-2,000,000
-1,500,000
Dividends paid
-523,000
-523,000
-455,000
-395,000
-337,000
Other financing activities
56,000
56,000
-9,000
65,000
-150,000
Net cash used provided by (used for) financing activities
-3,622,000
-3,622,000
-2,810,000
6,581,000
959,000
Net change in cash
-440,000
-440,000
4,046,000
-5,845,000
7,914,000
Cash at beginning of period
8,537,000
8,537,000
4,491,000
10,336,000
2,422,000
Cash at end of period
8,097,000
8,097,000
8,537,000
4,491,000
10,336,000
Free cash flow
Operating cash flow
8,406,000
8,406,000
9,154,000
9,312,000
8,289,000
Capital expenditure
-1,479,000
-1,479,000
-2,243,000
-2,523,000
-1,474,000
Free cash flow
6,927,000
6,927,000
6,911,000
6,789,000
6,815,000